Submitted by Anonymous (not verified) on 16 August 2023 - 14:56
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Thyroid Neoplasms, Date of authorisation: 16/02/2012, Revision: 52, Status: Authorised
Source: